INTRODUCTION:
Neuronal communication at excitatory synapses in the brain involves release of the neurotransmitter L-glutamate from the presynapse of one cell and its detection by postsynaptic ionotropic glutamate receptors (iGluRs) on another. A principal iGluR is the AMPA (a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor (AMPAR). On activation, AMPARs induce depolarization of the postsynaptic membrane to mediate rapid synaptic signaling and therefore precise information transfer at synapses. Longlasting changes in synaptic strength can occur through recruitment to, or removal of, AMPARs from the synapse in response to particular patterns of synaptic activity. These synaptic plasticity processes, such as long-term potentiation (LTP) or long-term depression (LTD), are considered a cellular basis for learning and memory.
AMPARs assemble into tetramers from four core subunits, GluA1 to GluA4, in various combinations. The GluA1/2 heteromer predominates throughout the forebrain and is selectively recruited during LTP at the intensely studied hippocampal CA3-CA1 synapse. Receptor function is further diversified by association with auxiliary subunits, such as the TARP (transmembrane AMPAR regulatory protein) family. TARP g8, a potent AMPAR modulator and the target for recent therapeutics, is selectively enriched in the hippocampus, forming a major component of the GluA1/2 signaling complex.
Within the AMPAR tetramer, the core subunits arrange in two conformationally distinct pairs, termed AC and BD, which play different roles in channel opening and are differentially modulated by TARPs. Although the BD pair has dominant control of activation in iGluRs, the rules of subunit arrangement in AMPARs are unclear.
RATIONALE: To elucidate the architecture and subunit organization of heteromeric AMPARs, we determined the structure of the GluA1/2 receptor in complex with TARP g8 by means of cryo-electron microscopy (cryo-EM). Because up to four TARPs can decorate an AMPAR tetramer, yet g8 appears to preferentially associate in a two-TARP stoichiometry, we fused g8 to the GluA2 subunit, which, when co-expressed with GluA1, allows production of GluA1/2 associated with two g8 auxiliary subunits. In addition, we used targeted mutagenesis in electrophysiological assays to probe subunit arrangement, gating properties, and mechanisms of TARP-specific receptor modulation.
RESULTS: Functional assays demonstrate preferential positioning of the GluA1 subunits to the AC positions, giving the functionally critical GluA2 (BD pair) dominant control over gating. The receptor assembly adopts an overall "Y" shape, characteristic of homomeric GluA2 structures, with the two extracellular domain layers [the N-terminal domain (NTD) and ligandbinding domain (LBD)], forming a dimer-ofdimers arrangement. The arms of the Y shape are held in place through an interface between the GluA2 NTDs, dictated by their positioning to the BD sites. The g8 subunits, associated through intramembrane interactions, locate beneath the LBD dimer-of-dimers interface, with their distinctly long extracellular loops selectively engaging the GluA2 LBD to modulate channel gating, whereas lipid-like cryo-EM densities are observed in cavities formed between g8 and the GluA1 TMD sector. Side chain resolution of the ion selectivity filter at the heart of the channel reveals the atomic details of the calciumrestricting "Q/R editing site," which critically determines the properties of heteromeric AMPAR assemblies throughout the brain.
CONCLUSION: This structural and functional characterization of the GluA1/2 TARP g8 complex reveals the architecture of a prominent AMPAR heteromer, offering a blueprint for deciphering signaling mechanisms of synaptic AMPARs.
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Organization of a GluA1/2 AMPA receptor heteromer associated with TARP g8. The GluA1/2 AMPA receptor with two TARP g8 auxiliary subunits (green) is depicted with schematic association of its agonist, glutamate (left). The GluA1 (blue) and GluA2 (red) subunits preferentially arrange to nonequivalent positions in the tetramer (right), giving GluA2 greater control of channel gating. (Inset) Representative contributions to glutamate-gated ion flow. A g8 loop (dashed line) interacts with the GluA2 ligand-binding domain to influence receptor gating. Here, we present a cryo-electron microscopy structure of the heteromeric GluA1/2 receptor associated with two transmembrane AMPAR regulatory protein (TARP) g8 auxiliary subunits, the principal AMPAR complex at hippocampal synapses. Within the receptor, the core subunits arrange to give the GluA2 subunit dominant control of gating.This structure reveals the geometry of the Q/R site that controls calcium flux, suggests association of TARP-stabilized lipids, and demonstrates that the extracellular loop of g8 modulates gating by selectively interacting with the GluA2 ligand-binding domain. Collectively, this structure provides a blueprint for deciphering the signal transduction mechanisms of synaptic AMPARs.
I
onotropic glutamate receptors (iGluRs), tetrameric cation channels gated by L-glutamate, are the primary mediators of signal transmission at excitatory synapses in the brain (1, 2) . Two principal iGluR subtypes, NMDA (Nmethyl-D-aspartate)-and AMPA (a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid)-type receptors (NMDARs and AMPARs, respectively), coexist at synapses, with complementary roles in synaptic communication. AMPARs drive baseline transmission, whereas NMDARs trigger synaptic plasticity, inducing long-term changes in synaptic efficacy. A prominent mechanism of synaptic plasticity is the recruitment or removal of synaptic AMPARs through processes such as long-term potentiation (LTP) or depression (LTD), which are considered to be cellular mechanisms that underlie learning and memory (3) .
Synaptic signaling and trafficking of iGluRs are determined by their subunit composition. The four AMPAR subunits, GluA1 to GluA4, assemble into heterotetramers of various compositions, preferentially containing the GluA2 subunit (1) . RNA editing of GluA2 changes a glutamine to an arginine at a site in the conduction pore (the Q/R site) (4) . Through this mechanism, the GluA2 subunit controls Ca 2+ permeability (5-7), channel block by polyamines (8-10), channel conductance (11) , and subunit assembly (1, 12) . Editing at this site is essential for survival of the organism (13) .
iGluRs are composed of two conformationally distinct, diagonally opposed subunit pairs termed AC (or "pore-proximal") and BD (or "pore-distal") ( Fig. 1A) (14) . The BD chains dominate channel gating and in NMDARs are occupied by the GluN2 subunits (15, 16) ; however, the subunit placement rules of heteromeric AMPARs have not been firmly established.
AMPAR tetramers associate with various auxiliary subunits (1, 17) . Principal among these are proteins from the TARP (transmembrane AMPAR regulatory protein) family, with subtypes associated with AMPARs across the brain, controlling receptor trafficking, gating, ion permeation, and pharmacology (1, 18, 19) . The six TARPs belong to three subgroups (Ia, Ib, and II), with the cerebellar TARP, g2 or stargazin (group Ia), being the most extensively studied. Structural studies of GluA2 homomers in complex with g2 show that up to four g2s can associate around the AMPAR transmembrane sector, with their two extracellular segments (Ex1 and Ex2) (Fig. 1B) poised to interact with the ligand-binding domain (LBD) (20, 21) .
Although g2 controls AMPAR function in the cerebellum, GluA1/2 heteromers associated with TARP g8 are the most abundant AMPAR complex in the hippocampus (19, 22) , the seat for episodic memories, driving the majority of synaptic transmission (23) and mediating synaptic plasticity at the Schaffer collateral-CA1 synapse (3, 24) . Thus far, structural studies have focused on homomeric GluA2 complexes, which appear to play no appreciable role in synaptic transmission (23) , whereas structural insights into the architecture of both GluA1 and g8 are so far absent, and only a single heteromeric AMPAR structure has been reported (GluA2/3) (25).
Here, we present structural and functional studies elucidating the organization of the GluA1/2 receptor in complex with TARP g8. We demonstrate preferential placement of the GluA2 subunit in the gating-dominant BD position, reveal the AMPAR-g8 contacts at side chain resolution, and describe a g8 Ex1 interaction with the upper lobe of the GluA2 LBD, which modulates gating. This structure also offers a view of the predominant Q/R site configuration in the selectivity filter and reveals strong density indicative of annular lipids. These line the channel fenestrations above the Q/R site, specifically stabilized between GluA1 and g8, where they have the potential to modulate ion flux.
Functional characterization of g8-associated GluA1/2 receptors AMPARs contain two nonequivalent positions for TARP association, the A′C′ and B′D′ sites (Fig.  1A ) (21) , resulting from a switch between the fourfold symmetric ion channel and a twofold symmetric LBD layer (14) . Structural studies with g2 suggest that TARPs preferentially occupy the B′D′ position (20) . Although not firmly established (26) , type Ib-TARPs (g4 and g8) appear to preferentially associate with the AMPAR in a two-TARP stoichiometry (two TARP subunits per receptor tetramer) (22, 27, 28) , especially in the hippocampus, where g8 is known to co-assemble with other AMPAR auxiliary subunits, such as cornichon homolog 2 (CNIH-2) (22) .
We studied a GluA1/2 receptor [both flip splice variants, and GluA2 edited at the Q/R and R/G sites (29, 30) ] associated with two g8 subunits, by coexpressing GluA1 with GluA2 in the "TARPtandem" configuration (26) , where the C terminus of GluA2 is fused to the N terminus of g8 (GluA2_g8), in human embryonic kidney (HEK) 293 cells. The resulting two-TARP complex, termed "A1/2_g8," elicited glutamate-evoked currents characteristic of TARP-associated AMPARs, with slowed deactivation and desensitization kinetics compared with those of TARP-free GluA1/2 ( Fig. 1C and fig. S1A ). Equivalent results were obtained by expressing a GluA1_g8 fusion with GluA2 ( Fig. 1C and fig. S1 , A to D). A functional comparison with a four-TARP stoichiometry was achieved by coexpressing GluA1/2 with an excess of free g8, allowing the association of four g8 subunits. The increased g8 occupancy showed a resensitizing current, a hallmark of AMPARs associated with four g8s ( fig. S1B ) (28) , larger steady-state currents ( fig. S1C) , and a subtly slower entry into desensitization ( fig. S1A ), whereas two TARPs were sufficient for maximal effects on receptor deactivation and recovery from desensitization ( Fig. 1C and fig. S1D ). Thus, this A1/2_g8 configuration presents a functional AMPAR-TARP complex (28) , allowing mechanistic studies of how these auxiliary subunits act to modulate gating of the receptor heteromer.
Subunit arrangement in GluA1/2 AMPARs
We probed the arrangement of the GluA1 and GluA2 subunits in the tetramer using two functional assays. The M3 linkers, which connect the channel gate to the LBD, show conformational differences between AC and BD chain pairs, implying that the BD linkers exhibit a greater pulling force on the gate (31, 32) . If GluA2 predominantly occupies the BD positions in GluA1/ 2 heteromers, as has been suggested (33) , then mutation of the GluA2 M3 linker would have a dominant effect on gating in the heteromer. To test this, we mutated an isoleucine residue, which controls linker tension by associating with the lower lobe of the LBD (I629 in GluA1 and I633 in GluA2; denoted "IA" mutation). This mutation attenuates gating in GluA2 homomers, with no influence on receptor surface trafficking (fig. S7E) (31) . As anticipated, this mutation severely limited channel activation in both GluA1 and GluA2 homomers (Fig. 1D) . In heteromeric receptors, mutation of GluA2 reduced receptor gating to a greater extent than mutating GluA1 (Fig.  1E) , supporting an arrangement with GluA2 preferentially in the pore-distal BD positions. (Singleletter abbreviations for the amino acid residues are as follows: A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gln; R, Arg; S, Ser; T, Thr; V, Val; W, Trp; and Y, Tyr. In the mutants, other amino acids were substituted at certain locations; for example, C528L indicates that cysteine at position 528 was replaced by leucine.)
To extend this finding to TARP-containing receptors, we took advantage of the C528L mutation in the GluA2 M1 transmembrane helix that limits TARP modulation without preventing association with the receptor (C524L in GluA1, denoted "CL" mutation) (34) preferentially dock to the B′D′ site [(20) , and confirmed for g8 below], mutation of the M1 helix in only the AC subunits should affect the action of TARPs (Fig. 1F ). Combining CL mutation of both GluA1 and GluA2 subunits in the A1/2_g8 complex sped receptor desensitization and reduced steady-state currents ( Fig. 1 , G to I), which is consistent with prevention of TARP modulation ( fig. S1 , A and C). However, when mutating either the GluA1 or GluA2 subunit, only GluA1 CL but not GluA2 CL exhibited "TARPfree," quickly desensitizing responses ( Fig. 1H ) and trend-wise reduced steady-state currents (Fig. 1I) . Therefore, placement rules in GluA1/2 heteromers dictate that GluA1 preferentially occupies the pore-proximal and GluA2 the poredistal positions, both in the absence and presence of g8, providing GluA2 with dominant control of receptor gating.
Cryo-electron microscopy (cryo-EM) structure of a GluA1/2-g8 receptor Overall architecture of the full-length receptor
The A1/2_g8 receptor (wild-type sequence, except for a 23-residue truncation of the GluA2 C terminus for TARP fusion) was extracted from HEK Expi293F TM cells in digitonin ( fig. S2 , A to C), trapped in a resting state with the competitive antagonist NBQX (6-nitro-2,3-dioxo-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide), and imaged with a Titan Krios microscope equipped with a K2 Summit detector and a Volta phase plate ( fig. S2D ). Three-dimensional (3D) classification and refinement resulted in a model with a homogeneous transmembrane domain (TMD)-LBD sector and a heterogeneous Nterminal domain (NTD) layer (figs. S2E and S3), a feature commonly observed with AMPARs (25, (35) (36) (37) . Further 3D classification resulted in models with incompletely resolved NTDs rather than discrete conformations, suggesting a continuum of conformers ( fig. S3) . A subset of particles exhibiting a clear three-layered, Y-shaped structure produced a map with an overall resolution of 6.3 Å, with highest resolution in the LBD/ TMD/TARP sector (figs. S3B and S4, A, B, and E). Rigid body fitting of crystal structures from individual AMPAR domains provided a first model of a GluA1/2 heteromer comprising the NTD layer, the LBDs, and the TMD surrounded by two g8 subunits in the B′D′ positions (Fig. 2, A to D) . Subunit identification was aided by a subunit-specific glycosylation signature of the GluA1 NTD. Clearly resolved glycosylation at Asn 45 was visible on AC chains but not BD chains (Fig. 2, E and F) , providing structural confirmation of the localization of GluA2 to the functionally dominant pore-distal position, in accordance with the functional data ( Fig. 1, G to I) .
Features of the NTD-layer
The Y-shape of A1/2_g8 is established by an interface between the GluA2 NTDs (Fig. 2 , A to C), a hallmark of homomeric GluA2 receptors that is also observed in crystal structures of isolated GluA2 and GluA2/3 NTDs (14, 25, 38) . The center of mass (COM) distance between NTD and LBD layers is increased by~4.5 Å compared with GluA2 structures with shortened NTD-LBD linkers (14, 20) . However, relative to wild-type GluA2 [Protein Data Bank (PDB) code 4UQJ], the interlayer distance is reduced by~3 Å (COM 63 Å versus 65.8 Å), resulting in a closer apposition of the GluA1 NTD and LBD ( fig. S5, A and B) . A charged loop (GluA1 residues L170 to E179), emanating from the most flexible NTD segment (helix aF) (39), together with an N-glycan projecting from the NTD at N231 are poised to mediate interlayer contacts with the LBD (fig. S5 , B and C). In another iGluR family member, GluD, a helical extension of the equivalent NTD aF engages the LBD for interlayer signaling (40) . This raises the possibility that this region could play a more general role in iGluR function.
Relative to GluA2 homomers in the resting state (PDB codes 3KG2 and 5KBU), we observed rearrangements of the NTD layer, including a clockwise rotation of the entire layer around the overall twofold axis of symmetry and a wider opening angle between the NTD dimers ( fig. S5D ). There was also a visible loosening of the GluA1/2 NTD dimer compared with homomeric crystal structures, which is unexpected given the high stability of this interface (41, 42) . Whether this is caused by the presence of the receptor core is currently unclear and requires higher-resolution structures.
Structure of the A1/2_g8 LBD-TMD sector
To improve resolution of the LBD/TMD/TARP sector, we masked the NTD and carried out consecutive steps of focused refinement, followed by 3D classifications without alignment ( fig. S3 ). This procedure gave rise to a model with an overall resolution of 4.4 Å, with the TMD layer and the ion conduction pore reaching 3.4 Å (Fig. 3A and figs. S3 and S4, C to E). Model building was aided by side chain density throughout the TMD/TARP region; most of the M1 and M3 linkers, which connect the LBD to the TMD; and parts of the LBD (Fig. 3, A and C, and fig. S6, A to D) .
Features of the GluA1/2 LBD layer
The LBDs, bilobate "clamshell" structures that coordinate L-glutamate and competitive antagonists in their interlobe cleft (43) , are arranged as two heterodimeric pairs and adopt a conformation characteristic of resting-state AMPARs ( Fig. 3, A and B) (35, 44) . Density for the competitive antagonist NBQX is apparent in the interlobe cleft of the GluA1 and GluA2 LBDs, forcing the clamshells into a cleft-open, antagonized conformation ( fig. S7 , A and B) (43) . A closer inspection suggests that the GluA2 LBD cleft is subtly more closed relative to GluA1 (bỹ 2°), which is possibly related to the greater pulling force exerted by subunits in the BD positions (32, 44) .
The stability of the LBD dimer interface, formed between the upper LBD lobes, is a central determinant of gating kinetics (45) and is tuned by alternative splicing (at the flip/flop exons of both GluA1 and GluA2) (30) and by RNA editing at the GluA2 R/G site (29) fig. S7C ).
The LBD dimers associate to form a "gating ring" (Fig. 3B ) that opens in an iris-like fashion upon receptor activation between helices G of the AC chains ( fig. S7D) (35) . The central opening of the ring is within the range of GluA2 restingstate structures associated with TARP g2 (PDB 5KBU and 5KK2), and the height of LBD layer, relative to the plane of the membrane, is also comparable with these structures (fig. S7E ). The base of the LBD connects through linkers to the TMD to transduce binding of L-glutamate to opening of the ion channel (Fig. 3, A and C,  and fig. S7E ).
The TMD sector
The outer gate, formed by a helical bundle of the four M3 transmembrane helices, adopts a closed conformation, as expected for a restingstate channel (31, 35) , and is "capped" by the GluA1 M625 side chains, projecting toward the pore axis ( fig. S8A ). The level of constriction at the narrowest point (A617 in GluA1 and A621 in GluA2) is similar to resting-state GluA2 determined at a comparable resolution (PDB code 3KG2). The importance of this region is highlighted by a rare mutation of this conserved Ala to Thr in GluA3, which stabilizes the closed-gate conformation and is linked to severe intellectual disability (46) . The structural deviation of the M3 gating linkers between the AC and BD chains (14, 31, 44) exemplify how the horizontally oriented GluA2 linkers exert gating dominance (Fig. 3C) . We also see side chain density of the Ile residues that determine linker tension (GluA1 I629 and GluA2 I633) (31) and of the arginines that shape desensitization (GluA1 R624 and GluA2 R628) (47) .
The inner pore constriction is formed by the M2 pore loop. At its apex, where GluA1 contains a glutamine (Q582), RNA editing at the Q/R site introduces Arg 586 into GluA2 (Fig. 3D) (4) . This arginine provides key signatures of heteromeric AMPARs: preventing both Ca 2+ ion permeation and polyamine block (1). Our structure shows that the GluA2 R586 guanidinium groups project into the water-filled cavity above, ideally positioned to restrict cation influx (5-7, 11) , whereas the GluA1 Q582 side chains bend toward the adjacent GluA2 subunit, in H-bonding distance of the R586 main chain and the Q587 side chain (the +1Q), effectively lining the "entrance" of the selectivity filter (Fig. 3, D and E) . Deeper into the filter, the +1Q side chains swing anticlockwise (when viewed from the top) in all four subunits to interact with a tryptophan projecting from the M3 helix (GluA1 W602 and GluA2 W606) of the neighboring subunit (Fig. 3E) .
The pore diameter at the filter entrance, measured at the R586 Ca atoms, is comparable with a GluA2 homomer trapped in an active state at a comparable resolution (PDB code 6DLZ; distance 11.7 Å in A1/2_g8 versus 10.7 Å in 6DLZ) ( fig. S8, B and C R599) (fig. S8E ). This behavior is reminiscent of the related K + channels (48) but deviates from transient receptor potential (TRP) channels, where both the outer gate and selectivity filter widen on activation (49) . There also is strong density within the filter, close to the +3 cysteine (Fig. 3D and fig. S8F ), a residue modified by palmitoylation (50) . Although unlikely to be palmitoyl groups because of the side-chain geometry, the nature of this density is currently uncertain. The cytoplasmic entrance to the filter, which contributes to polyamine binding and channel rectification, is lined by a ring of aspartate residues (GluA1 D586 and GluA2 D590) (Fig. 3D  and fig. S8G ).
Lipid-like densities decorate the TMD
We observed strong density associated with the receptor, perpendicular to the presumed plane of the membrane. These signals are characteristic of lipid molecules, although further work and 4 of 10 higher-resolution structures are required to ascertain this (Figs. 3A and 4A) . Marking the boundary of the outer-membrane leaflet, these densities specifically fill the cavity between g8 and the GluA1 subunit, where they line the GluA1 pre-M1 "cuff helix" (Fig. 4B ) but are absent from the equivalent region of GluA2 (Fig. 4, C and D) . This suggests that they may be stabilized by the presence of g8. We modeled five lipid molecules (L1 to L5) in this cavity, while an additional molecule (L6) locates to the perimeter of g8, next to W86 (Fig. 4, A, C, and D) . Of note, L6 mirrors lipid density located at an analogous Trp residue, W49 ( fig. S9A ), in a crystal structure of claudin-15 (PDB 4P79), a protein structurally related to g8 (51). The presumed head groups of L1 and L2 engage the extracellular b-sheet of g8-at Y45 (b1) and H197 (b5), respectively-with their acyl chains packing against the TARP and receptor (g8-TM4 and GluA1-M1), respectively (Fig. 4A) . The third lipid, L3, fills the periphery of the cavity, connecting L1 and L2 to L4 and L5 (Fig.  4, C and D) .
The density of L4 projects diagonally toward the lateral portals of the channel above the Q/R site, between the GluA1 M1 and M4 helices, engaging the M2 helix through F580 and M581 (Fig. 4B ). L4 and L5 are positioned by interactions with the densities of L2 and L3 as well as a number of GluA1 residues along M1 (Y529), M4 (I794, L801), the M1 cuff (F511), and M3 of GluA2 (F607). The location of L4, at the heart of the channel, gives it the potential to control ion flux, perhaps in a g8-dependent manner. A comparably positioned lipid has recently been observed in molecular dynamics simulations of the NMDAR channel (52) . Lipids are known to modulate other pore-loop channels such as the closely related kainate receptors (KARs), dependent on the Q/ R-editing state (53) , and can penetrate into the fenestrations of voltage-gated sodium channels, where they may occupy docking sites for hydrophobic drugs (54) .
The TARP g8 interaction region TARP g8 docks to the receptor TMD through its TM3 and TM4 helices, forming extensive contacts with M1 of GluA1 and M4 of GluA2 (Fig. 5, A  and B) . Whereas g8-TM4 almost exclusively engages GluA1 (M1), g8-TM3 wedges between both subunits, effectively cross-linking M1 and M4 of the receptor (Fig. 5B) . As a result of this, GluA1-M1 and GluA2-M4 pack more tightly upon g8 interaction compared with the TARP-free A′C′ TARP-docking site (Fig. 5C ). On closer inspection, comparison of the A′C′ and B′D′ sites reveals rearrangements that accompany the binding of g8, with the GluA1 Y519 and M523 side chains swinging toward the TARP to facilitate formation of an H-bond between E520 of the receptor and Y199 of the TARP (Fig. 5D) .
The side-chain resolution in the TARP interaction region (Fig. 5 , E and F) permitted us to visualize the residues responsible for binding of recently described g8-specific antagonists, which hold promise in epilepsy treatment (55, 56) . Ligand specificity over other TARPs is conferred by two residues in the g8 TMD, V176 in TM3 and G209 in TM4, which pack against M1 of the AMPAR in the vicinity of M523 and C524 (in GluA1) (Fig.  5B) . Although the specificity-determining residues in g8 are less bulky than those of other TARPs (Val and Gly compared with Ile and Ala), our structure does not suggest a binding pocket large enough to accommodate the modulators. Together with recent studies showing that these antagonists can bind to free g8 (57), larger-scale conformational changes, triggered by association of liganded g8 with the receptor, may occur to functionally uncouple TARP and receptor.
Comparison of g8 with other TARP-like proteins
Superposition of g2 and g8 reveals close structural similarities, including alignment of the four transmembrane helices (root mean square deviation 3.14 Å), and arrangement of the extracellular region (ECR), formed of the pre-TM2 helix and a five-stranded b-sheet (Fig. 1B and fig. S9 ). The three loops emanating from the b-sheet, the b1-b2 and b4-TM2 loops (both in Ex1) and the TM3-b5 (Ex2), project toward the LBD and modulate gating kinetics (Fig. 1C) (20, 21, 58) . As is the case in current g2 structures, these loops are incomplete in our 4.4 Å map because of their inherent flexibility (Fig. 3A) .
There are a number of marked differences between TARPs and structurally related proteins, the AMPAR auxiliary subunit GSG1L, and claudins ( fig. S9 ). Claudins exhibit tighter packing of the four-helical bundle and a substantial reorientation of the pre-TM2 helix ( fig. S9E) (51) . Whereas in claudins, this pre-TM2 element contributes to formation of epithelial tight junction arrays, in TARPs, pre-TM2 swings toward the AMPAR M4 helix (M4 of GluA2 in A1/2_g8) to position the modulatory b4-TM2 loop beneath the LBD (Fig.  5A) (44) . This "acidic loop," which is enriched in negatively charged residues, has been implicated in interactions with the basic "KGK" motif within the LBD lower lobe (20, 21, 34, 58, 59) . TM2 is contiguous in GSG1L (60), and pre-TM2 is absent, presumably owing to the lack of a proline (P131 in g8) giving rise to the TM2 kink at the AlaSerSer motif ( fig. S9, A to D) , resulting in reorientation of its acidic b4-TM2 loop (60) and likely has consequences for AMPAR modulation by GSG1L versus TARPs.
g8 interactions with the GluA2 LBD
The mechanisms by which the flexible TARP loops engage the LBD to modulate gating are not completely understood (61) . Dictated by the heteromeric subunit organization, the g8 loops will primarily engage the functionally dominant GluA2 subunit (Fig. 3B) . The shorter loop of the Ex2 segment (TM3-b5) reaches toward the LBD-TMD linkers, and we see contacts with K511 in the GluA2 LBD-M1 linker ( fig. S10 ), whereas the two loops in Ex1 are expected to predominantly engage the LBD. The greater modulatory potency of g8 versus g2 has been ascribed to its distinctive b1-b2 loop, which is 12 residues longer, allowing it to more easily reach the LBD (59, 62, 63) . Although density for the Ex1 loops was fragmented in our 4.4-Å map, processing of the entire data set without masking (~900,000 particles) resulted in a 4.7-Å map that revealed additional signal between g8 and the GluA2 LBD. Whereas the NTD layer had poor resolution because of heterogeneity, density can be seen emanating from the Ex1 b1-b2 strands toward a loop (M408-R420) on the upper lobe of the GluA2 LBD Herguedas et al., Science 364, eaav9011 (2019) 26 April 2019
6 of 10 ( Fig. 6A) . This observation suggests that g8 is able to reach the LBD upper lobe, with the b1-b2 loop spanning a distance of~40 Å (between Ca atoms of g8 H197 and GluA2 K409) (Fig. 6B) .
To test the functional consequence of disrupting this potential interaction, we introduced an N-glycan in the LBD loop at N411 in GluA2 and assayed responses to rapid application of L-glutamate. The GluA2 LBD mutant ("E413T") indeed exhibited desensitization kinetics and steady-state responses comparable with those of GluA1/2 in the absence of g8 and significantly different to those of A1/2_g8 wild type but was of no effect when introduced into the GluA1 LBD (at N407 using the "N409T" mutation) (Fig. 6, C  and D, and fig. S11, A to C) . Moreover, the GluA2 glyco-mutant retained TARP modulation when assayed in the context of g2, which has a shorter b1-b2 loop (Fig. 6, C and D, and fig. S11, A to C) . These data suggest that the interaction site in the LBD upper lobe is selectively required for the modulatory action of TARP g8.
Discussion
This structure of the GluA1/2 heteromer in association with two TARP g8 subunits provides a framework for deciphering the inner working of the primary hippocampal AMPAR (22) (23) (24) 28) , which drives synaptic strengthening during LTP (64) (65) (66) (67) . The arrangement of the four core subunits, with GluA2 preferentially in the functionally dominant BD position, explains why g8 primarily targets GluA2 in our resting-state structure. An additional major component in regulation of the hippocampal AMPAR complex is the auxiliary subunit CNIH-2 (22, 28, 34) . Future work will resolve how CNIH-2 interacts with AMPAR and how this relates to TARP binding. Whether the subunit placement rules described for GluA1/2 apply to other AMPAR heteromers is another crucial question. GluA2 was detected in both AC and BD positions of the GluA2/3 receptor (25) , raising the possibility that the subunit arrangement in GluA2/3 receptors could be more flexible. Placement rules, perhaps controlled by signal sequence parameters on initial assembly (33), will have consequences for gating control, modulation by auxiliary subunits, and organization of the NTD layer (25), a platform for AMPAR positioning at synapses (68, 69) . Last, we hypothesize that the asymmetric distribution of lipid-like densities, proximal to the g8 b1 and b5 strands, is caused by TARP g8 and may point to an additional regulatory capacity of auxiliary subunits, either by influencing the local lipid environment of synaptic receptors or by modulation of channel properties through lipids, analogous to KARs (53) .
Materials and Methods cDNA Constructs
All constructs and mutations were produced using IVA cloning (70) . cDNAs encoding rat wildtype GluA2 (flip, R/G, Q/R) and rat GluA1 (flip) were expressed from either the pRK5 or pIRES plasmids. Rat TARP g8 was expressed from pIRES-eGFP construct. Tandem constructs (pRK5) were produced by connecting the C terminus of GluA2 (excluding residues Gln840-Ile862) or GluA1 (excluding residues Ile836-Leu889) through a GGSGSG linker to the N terminus of rat g8 (residues Glu2-Lys419; 4 amino-acid deletion). These are denoted A2_g8 and A1_g8 respectively. GluA1 C524L and N409T and GluA2 C528L and E413T mutations were all produced on the pRK5 plasmids above. GluA1 I629A was expressed from pIRES-mCherry construct and GluA2 I633A was expressed from pIRES-eGFP construct. TARP g2 tandems were produced as per g8 tandems by fusing the rat g2 coding sequence (Glu2-Arg319) to the C terminus of GluA2 with the equivalent linker sequence.
For protein purification, the plasmids described above were modified by introducing two tags. For GluA1, a FLAG tag was inserted after the first residue of the mature protein (Ala1). For GluA2_g8, a 3C protease site (LEVLFQGPGGS), eGFP (Val2-Lys239) and a GGSHHHHHHHH His-tag sequence were added to the C terminus of g8 ( fig.  S2A ). pOPINE-GFP nanobody plasmid (Addgene #49172) was used for the production of the GFP nanobody (71) .
Electrophysiology
HEK293T cells (ATCC: Cat# CRL-11268, RRID: CVCL_1926, Lot 58483269: identity authenticated by STR analysis, mycoplasma negative), cultured at 37°C and 5% CO 2 in DMEM (Gibco; high glucose, GlutaMAX, pyruvate, Cat#10569010) supplemented with 10% foetal bovine serum (Gibco) and penicillin/streptomycin, were transfected using Effectene (Qiagen) according to manufacturer protocol and plated on poly-L-lysine-coated glass coverslips. 30 mM 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; Tocris) was added to media posttransfection to avoid AMPAR-mediated toxicity.
Outside-out patches (or lifted whole-cells for IA mutant analysis), voltage clamped at -60 mV, were subject to fast application of L-glutamate (10 mM unless otherwise stated) using a twobarrel theta glass tube controlled by a piezoelectric translator (Physik Instrumente). Signals were acquired using the MultiClamp 700B or Axopatch-200B amplifier (Axon Instruments), digitised using a Digidata 1440A interface and recorded with pClamp 9 or 10 (Molecular Devices). Extracellular solution contained (in mM) NaCl (145), KCl (3), CaCl 2 (2), MgCl 2 (1), glucose (10) , and HEPES (10), adjusted to pH 7.4 using NaOH. Borosilicate glass electrodes (1.5mm o.d., 0.86mm i.d., Science Products GmbH), pulled with a PC-10 vertical puller (Narishige) with tip resistance of 2 to 5 megohms, were filled with internal solution containing (in mM) CsF (120), CsCl (10), EGTA (10), ATP-sodium salt (2), HEPES (10) , and spermine (0.1), adjusted to pH 7.3 with CsOH.
When recording heteromeric responses, 20 mM IEM 1925 dihydrobromide (Tocris) was added to extracellular solutions to block currents contributed by GluA2-lacking receptors. For heteromeric recordings, the I/V relationship of glutamate responses (from -100 to 100 mV) was recorded, rectification index [RI: (I 40mV -I 0mV )/(I -60mV -I 0mV )] calculated, and cells with a RI of <0.6 were discarded. Desensitization entry was determined by 500 ms glutamate application and the first 200 ms was fitted with a twoexponential function to obtain the (weighted) time constant. Recovery from desensitization was tested using a two-pulse protocol consisting of a desensitizing 500 ms pulse followed by a 10 ms pulse at increasing time intervals. Recovery curves were initially fitted with the Huxley-Hodgkin equation, which produced an exponent value close to 1, [as previously described (72)], suggesting a single rate-limiting transition in desensitization recovery. Consequently, all recovery rates were determined by monoexponential fit. Steadystate current was measured 200 ms after peak and expressed as a percentage of the peak current amplitude. Deactivation kinetics were measured by 2 ms glutamate application and responses were fitted with biexponential decay to acquire the weighted deactivation time-constant. Resensitization was recorded by 10 s glutamate applications and quantified using the percentage of peak amplitude that recovers between 200 ms and 10 s post peak amplitude. Whole-cell peak amplitude was determined from the mean peak response of 5 consecutive sweeps, and is presented as box and whisker plots depicting 5 to 95 percentile range. All other data are presented as mean value ± standard error of the mean.
Protein production
GFP nanobody was produced in Escherichia coli BL21-Gold and purification was carried out as previously described (71) . GFP nanobody was coupled to CNBr Activated Sepharose 4b beads (GE) following manufacturer protocols. For the production of the A1/2_g8 complex, DNAs coding for GluA1_FLAG and GluA2_g8_eGFP were transfected into HEK-Expi293F TM cells (Thermo Fisher Scientific) grown in Expi293 TM expression media (Gibco). For transfection, 33 ml of Expi293 TM media containing 0.55 mg of GluA1_FLAG-pRK5 and 0.55 mg of GluA2_g8_eGFP-pRK5 were mixed with 33 ml of Expi293 TM media containing 3 mg of PEI-max (Polyscience), incubated for <15 min at room temperature and added to 1 l of cells (density of 2 × 10 6 cells/ml). To block AMPAR currents, media was supplemented with ZK200775 (2 nM) and kynurenic acid (0.1 mM). 36-48 hours posttransfection, cells were harvested and lysed for 1.5 hours in buffer containing 25 mM Tris pH 8, 150 mM NaCl, 0.75% digitonin (w/v) (Sigma), 5 mM NBQX, 1 mM PMSF, 1x PI (Roche). Insoluble material was removed by ultracentrifugation (41,000 rpm, 1 hour, rotor 45-50 Ti) and the lysate was incubated with anti-GFP beads for 2 hours. Beads were washed with 0.1% digitonin and the protein was eluted by digestion with 3C protease (the first elution was done overnight at 4°C and the second elution was done for 4 hours at 4°C). Eluted fractions contained A1/2_g8 heterotetramers and GluA2_g8 homotetramers ( fig. S2B ). Pooled fractions were incubated with FLAG magnetic beads (Sigma), washed with 0.1% digitonin, and the A1/2_g8 heterotetramer was eluted with 0.15 mg/ml 3xFLAG peptide (fig. S2B ). Eluted fractions were pooled and concentrated tõ 0.4 mg/ml in 25 mM TRIS, pH 8, 150 mM NaCl and 0.1% digitonin (w/v).
Cryo-EM grid preparation and data collection
Protein was incubated with 50 mM NBQX for at least 30 min on ice prior to grid preparation. Quantifoil Cu 1.2/1.3 grids (300 mesh) coated with an ultrathin layer of amorphous carbon (2 nm-thin from Quantifoil or home-made) were glow-discharged for 7 s at 0.35 mA. 3 ml of sample were applied to the grids for 60 s, blotted for 2.5 to 3.5 s and plunged-frozen in liquid ethane with a FEI Vitrobot Mark IV equilibrated at 4°C and 100% humidity. Cryo-EM data were acquired at Diamond Light Source (DLS) electron BioImaging Centre (eBIC) on an FEI Titan Krios IV operated at 300 keV, with a K2 Summit detector (Gatan) operated in counting mode, a GIF Quantum energy filter (slit width 20 eV) and a Volta phase plate. Three datasets were collected using EPU, with 5006 micrograph movies in total. Each movie contained 35 movie frames collected at a dose rate of 4.5 e -/pixel/s over 14 s, resulting in a total dose of~32 e -per Å
2
. The magnification used was 105,000×, resulting in a pixel size of 1.40 Å on the specimen.
Cryo-EM data processing and model building
Data were processed using RELION 3.0 (73). Stage drift correction, beam induced motion correction and dose-weighting were performed with MOTIONCORR2 (74) using 5 by 5 patches. CTF correction and phase shift estimation were performed with Gctf 1.06 (75) . Defocus values ranged from -0.2 mm to -1.4 mm. Phase plate position was changed every 45 images. Autopicking was performed using a Gaussian blob, and particles were extracted in a box of 220 pixels. For each of the three datasets we performed 2 or 3 rounds of 2D classification with particles binned to a 50-pixel box, before re-extracting and performing a last round of classification at full pixel size. For 3D classification we created an ab initio model starting from 12,000 particles, which was low-pass filtered to 40 Å. For Dataset 1, we performed two rounds of 3D classification that allowed us to remove models that were not showing AMPAR-like features and particles that were too close together. All AMPAR models showed clear TMD and LBD sectors, whereas the third layer, corresponding to the two NTD dimers, was heterogeneous ( fig. S3) . We pooled the particles containing quality TMD and LBD features and performed refinement in C2 symmetry with a mask that excluded the NTD layer. We performed a similar 3D classification and refinement approach for the three datasets, yielding three maps for TMD/LBD at 5.0 Å, 4.4 Å, and 4.8-Å resolution, respectively ( fig. S3) . Particles from the three datasets were pooled together and refined with C2 symmetry, obtaining a map at 4.3-Å resolution, which was not showing sidechain density (1,057,013 particles). Two steps of 2D classification (without alignment) allowed us to further clean the dataset, obtaining a refined model at 4.3-Å resolution showing improved features (899,088 particles). This set of particles was further classified to obtain a full-length receptor map and a TMD/LBD receptor map ( fig.  S3 ). The full-length map was obtained after a step of 3D classification with alignment in 5 classes, followed by a refinement (using C2 symmetry), a step of 2D classification, and a second step of refinement (C2 symmetry). 183,811 particles contributed to the final model, which had an overall resolution of 6.3 Å after gold-standard resolution estimation in RELION (FSC = 0.143). Local resolution was calculated with RELION with the model displaying a resolution ranging from~5 Å in the TMD core to~7.5 Å in the NTD (fig. S4) . The TMD/LBD map was obtained after two rounds of 3D classification without alignment (C1 symmetry), which allowed us to isolate a subset of 114,730 particles that were subjected to refinement (C2 symmetry). During refinement, the low-pass filter effect of the Wiener filter in the regularized likelihood optimization algorithm was relaxed through the use of a regularization parameter (T = 2). This allowed the refinement algorithm to consider higher spatial frequencies in the alignment of the individual particles. Nevertheless, both half-reconstructions were kept completely separate, and the final resolution estimate (at the post-processing stage in RELION) was based on the standard Fourier shell correlation (FSC) between the two unfiltered halfreconstructions. The overall resolution of the resulting map was 4.4 Å (lower than the 899,088 particle dataset) with high-quality density, especially at the TMD region, which reached a local resolution of~3.4 Å, while~6.1 Å was achieved at the top of the LBD layer (local resolution calculated in RELION) ( fig. S4 ). The 899,088 particles were also refined without mask in order to investigate the density of the g8 loops, which were poorly defined in the TMD-LBD map. We refined the particles in C2 symmetry, obtaining a model at 4.7-Å resolution, which allowed us to identify an interaction between the g8 Ex1 and the LBD upper lobe (Met408-Arg420) (Fig. 6 and  fig. S3 ). Density for the NTD was very poor, highlighting the heterogeneity of this region.
For the TMD/LBD map, model building and refinement were performed using Coot (76) and REFMAC5 (77), using the CCP-EM suite of programs (78) . For modelling, the g2 in the GluA2-g2 complex (PDB code 5WEO), the GluA2 LBD (PDB 3UA8) and the transmembrane domain in the GluA2-g2 complex (PDB 5KK2) were taken as starting points. The individual coordinates were rigid-body fitted in Chimera (79) . Sequence assignment and initial manual modifications were performed in Coot, prior to jelly-body refinement in REFMAC5. Alternating rounds of manual modifications and restraint refinement were performed in Coot and REFMAC5 respectively. ProSMART (80) was used to generate restraints in order to maintain secondary structure in regions of lower local resolution. Atomic B-factors were reset to 40 Å
2 prior to refinement. Clear density for lipid-like molecules was found in the map; however, their identity could not be discerned based exclusively on the cryo-EM density. We therefore modeled all as single acyl chain lipids, taking the 1-oleoyl-R-glycerol as a representative general lipid. Overfitting in refinement was monitored throughout using the FSC work / FSC test ( fig. S6E ) (81) . The final model had good geometry (table S1 ) with validation performed in Coot, Molprobity (82) and EMRinger (83) . The model fit to the map was assessed using Phenix (84) using a global model-vs-map FSC correlation ( fig. S6) . Dimensions of the pore were calculated from the TMD/LBD protein model using the program HOLE (85) . Sequence alignment was created using PROMALS3D (86) . For the full-length model 1, rigid body fitting of the TMD/LBD model obtained above and single chains for the GluA1 NTD (PDB 3SAJ) and GluA2 NTD (PDB 3H5V) was performed in Chimera (79) .
